PREV_PKDL is a collaborative project funded by the European & Developing Countries Clinical Trials Partnership (EDCTP2) Programme supported by the European Union. The project is the joint effort of leading European and African experts with proven track records in research and development of products against leishmaniasis.

Funded by the European and Developing Countries Clinical Trials Partnership (EDCTP2)

The Team

  • European Vaccine Initiative (Germany): Dr Sophie Houard
  • University of York (UK): Professor Paul Kaye
  • Institute of Endemic Diseases (Sudan): Professor Ahmed Musa
  • Makerere University (Uganda): Professor Joseph Olobo
  • Kenya Medical Research Institute (Kenya): Dr Margaret Mbuchi,
  • University of Gondar (Ethiopia): Professor Asrat Hailu
  • London School of Hygiene & Tropical Medicine (UK): Professor Simon Croft
  • Royal College of Surgeons (Ireland): Professor David Smith
  • National Institute of Immunology (India): Professor Nirmal K Ganguly

For more information please click here

Posted on:

Comments are closed.